Editorial: is age just a number when it comes to treatment of inflammatory bowel disease? Authors' reply

Affiliations

Editorial

Vera E R Asscher et al. Aliment Pharmacol Ther. 2020 Nov.

. 2020 Nov;52(10):1617-1618.

doi: 10.1111/apt.16106.

No abstract available

Comment on

Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab- and ustekinumab-treated patients with inflammatory bowel disease-a prospective multicentre cohort study.
Asscher VER, Biemans VBC, Pierik MJ, Dijkstra G, Löwenberg M, van der Marel S, de Boer NKH, Bodelier AGL, Jansen JM, West RL, Haans JJL, van Dop WA, Weersma RK, Hoentjen F, Maljaars PWJ; Dutch Initiative on Crohn and Colitis (ICC). Asscher VER, et al. Aliment Pharmacol Ther. 2020 Oct;52(8):1366-1376. doi: 10.1111/apt.16073. Epub 2020 Sep 9. Aliment Pharmacol Ther. 2020. PMID: 32901983 Free PMC article.
Editorial: is age just a number when it comes to treatment of inflammatory bowel disease?
Ma C, Singh S, Heatherington J, Panaccione R. Ma C, et al. Aliment Pharmacol Ther. 2020 Nov;52(10):1615-1616. doi: 10.1111/apt.16098. Aliment Pharmacol Ther. 2020. PMID: 33085983 No abstract available.

1. Ma C, Singh S, Heatherington J, Panaccione R. Editorial: is age just a number when it comes to treatment of inflammatory bowel disease? Aliment Pharmacol Ther. 2020;52:1615-1616.
1. Asscher VER, Biemans VBC, Pierik MJ, et al. Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab- and ustekinumab-treated patients with inflammatory bowel disease-a prospective multicentre cohort study. Aliment Pharmacol Ther. 2020;52:1366-1376.
1. Geisz M, Ha C, Kappelman MD, et al. Medication utilization and the impact of continued corticosteroid use on patient-reported outcomes in older patients with inflammatory bowel disease. Inflamm Bowel Dis. 2016;6:1435-1441.
1. Asscher VER, Lee-Kong FVY, Kort ED, et al. Systematic review: components of a comprehensive geriatric assessment in inflammatory bowel disease-a potentially promising but often neglected risk stratification. J Crohns Colitis. 2019;13:1418-1432.
1. Kochar B, Cai W, Cagan A, Ananthakrishnan AN. Pretreatment frailty is independently associated with increased risk of infections after immunosuppression in patients with inflammatory bowel diseases. Gastroenterology. 2020;158:2104-2111; e2102.